Smruthi Organics Ltd
BSE:540686

Watchlist Manager
Smruthi Organics Ltd Logo
Smruthi Organics Ltd
BSE:540686
Watchlist
Price: 118.05 INR 1.03% Market Closed
Market Cap: ₹1.4B

Operating Margin

6.9%
Current
Improving
by 2.4%
vs 3-y average of 4.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
6.9%
=
Operating Income
₹82.8m
/
Revenue
₹1.2B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
6.9%
=
Operating Income
₹82.8m
/
Revenue
₹1.2B

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Smruthi Organics Ltd
BSE:540686
1.4B INR
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.2B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275.2B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.8B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
CH
Novartis AG
SIX:NOVN
220.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
269.2B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.4B USD
Loading...

Market Distribution

In line with most companies in India
Percentile
48th
Based on 5 437 companies
48th percentile
6.9%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Smruthi Organics Ltd
Glance View

Market Cap
1.4B INR
Industry
Pharmaceuticals

Smruthi Organics Ltd. engages in the manufacture and sale of bulk drugs and drug intermediates. The company is headquartered in Solapur, Maharashtra. The company went IPO on 2017-08-29. The Company’s operating segments include Formulation. The firm's products include AMLODIPINE BESILATE, AMISULPRIDE, CARBIDOPA, CIPROFLOXACIN, DILOXANIDE FUROATE, FENOFIBRATE, METFORMIN HYDROCHLORIDE, NORFLOXACIN, PEFLOXACIN, TELMISARTAN, AMLODIPINE BASE and PHTHALOYL AMLODIPINE. The firm has 2 manufacturing facilities in Solapur, Maharashtra. with a combined reactor capacity of over 320 kiloliters. The firm manufactures API from kilo to metric ton scale. The firm serves pharmaceutical companies in India and across the globe. The firm caters to both domestic and international markets.

SMRUTHIORG Intrinsic Value
236.83 INR
Undervaluation 50%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
6.9%
=
Operating Income
₹82.8m
/
Revenue
₹1.2B
What is Smruthi Organics Ltd's current Operating Margin?

The current Operating Margin for Smruthi Organics Ltd is 6.9%, which is above its 3-year median of 4.5%.

How has Operating Margin changed over time?

Over the last 3 years, Smruthi Organics Ltd’s Operating Margin has decreased from 7.6% to 6.9%. During this period, it reached a low of 0.5% on Sep 30, 2024 and a high of 7.6% on Aug 30, 2022.

Back to Top